Company Profile
Bio-Techne Stock Price, News & Catalysts
- Ticker:
- TECH
- Exchange:
- NASDAQ
- Sector:
- Life Science Tools
- Location:
- United States
Stock performance
72.39 USD (-0.01%)
Close
Last updated: August 17, 2026
7.79B USD
Market cap
Why the stock is moving
As of Aug 17, 2026, TECH was little changed and closed at $72.39. No new same-company headline was identified in the current news window.
Company overview
Life-Science Research Tools
Bio-Techne supplies proteins, reagents, instruments, and diagnostic products used across biological research, drug development, manufacturing, and clinical testing. Its portfolio serves academic laboratories, biopharmaceutical companies, and diagnostic customers worldwide.
R&D Systems
R&D Systems supports discovery, translational research, and bioprocessing with proteins, antibodies, assays, and related reagents. The portfolio includes GMP-grade proteins used in cell and gene therapy development and manufacturing.
Bio-Techne Spatial
The Spatial business provides technologies for analyzing the location and expression of biological targets within tissue. These tools connect molecular signals with tissue architecture in oncology and translational medicine.
Bio-Techne Diagnostics
The Diagnostics portfolio includes immunoassays, blood-chemistry and blood-gas quality controls, hematology controls, and custom reagents for diagnostic manufacturers and clinical laboratories.
Pending Acquisition
Bio-Techne has agreed to be acquired by Merck KGaA, Darmstadt, Germany. Until the transaction closes, it continues operating through its three customer-focused brands and global research and diagnostic infrastructure.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Bio-Techne (TECH)?
Bio-Techne (TECH) most recently closed at 72.39 USD, a -0.01% move versus the previous session.
What is the market cap of Bio-Techne (TECH)?
Bio-Techne currently has a market capitalization of 7.79B USD on BioPharmSignal.
What does Bio-Techne do?
Life-Science Research Tools Bio-Techne supplies proteins, reagents, instruments, and diagnostic products used across biological research, drug development, manufacturing, and clinical testing. Its portfolio serves academic laboratories, biopharmaceutical companies, and diagnostic customers worldwide. R&D Systems R&D Systems supports discovery, translational...
On which exchange is TECH stock listed?
Bio-Techne (TECH) is associated with NASDAQ, United States, Life Science Tools.
What is Life-Science?
Life-Science Research Tools Bio-Techne supplies proteins, reagents, instruments, and diagnostic products used across biological research, drug development, manufacturing, and clinical testing.
Which conditions is Bio-Techne targeting with Life-Science?
Bio-Techne is associated with oncology, hematology based on its company overview and current catalyst commentary.
What is Research?
Life-Science Research Tools Bio-Techne supplies proteins, reagents, instruments, and diagnostic products used across biological research, drug development, manufacturing, and clinical testing.
What is Tools?
Life-Science Research Tools Bio-Techne supplies proteins, reagents, instruments, and diagnostic products used across biological research, drug development, manufacturing, and clinical testing.